Inhibitors of difficult protein-protein interactions identified by high-throughput screening of multiprotein complexes.

Protein-protein interactions (PPIs) are important in all aspects of cellular function, and there is interest in finding inhibitors of these contacts. However, PPIs with weak affinities and/or large interfaces have traditionally been more resistant to the discovery of inhibitors, partly because it is more challenging to develop high-throughput screening (HTS) methods that permit direct measurements of these physical interactions. Here, we explored whether the functional consequences of a weak PPI might be used as a surrogate for binding. As a model, we used the bacterial ATPase DnaK and its partners DnaJ and GrpE. Both DnaJ and GrpE bind DnaK and catalytically accelerate its ATP cycling, so we used stimulated nucleotide turnover to indirectly report on these PPIs. In pilot screens, we identified compounds that block activation of DnaK by either DnaJ or GrpE. Interestingly, at least one of these molecules blocked binding of DnaK to DnaJ, while another compound disrupted allostery between DnaK and GrpE without altering the physical interaction. These findings suggest that the activity of a reconstituted multiprotein complex might be used in some cases to identify allosteric inhibitors of challenging PPIs.

[1]  J. Rogers,et al.  Allosteric Heat Shock Protein 70 Inhibitors Rapidly Rescue Synaptic Plasticity Deficits by Reducing Aberrant Tau , 2013, Biological Psychiatry.

[2]  J. Gestwicki,et al.  Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions , 2013, Chemical biology & drug design.

[3]  Catherine A. Collins,et al.  Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation , 2012, Nature chemical biology.

[4]  A. Mapp,et al.  Fine-tuning multiprotein complexes using small molecules. , 2012, ACS chemical biology.

[5]  Jason E. Gestwicki,et al.  Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.

[6]  Harry Jubb,et al.  Structural biology and drug discovery for protein-protein interactions. , 2012, Trends in pharmacological sciences.

[7]  E. Zuiderweg,et al.  Heat shock protein 70 kDa chaperone/DnaJ cochaperone complex employs an unusual dynamic interface , 2011, Proceedings of the National Academy of Sciences.

[8]  E. Zuiderweg,et al.  Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones. , 2011, Journal of molecular biology.

[9]  Wendell A. Lim,et al.  Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information , 2011, Science.

[10]  Lila M. Gierasch,et al.  Allosteric signal transmission in the nucleotide-binding domain of 70-kDa heat shock protein (Hsp70) molecular chaperones , 2011, Proceedings of the National Academy of Sciences.

[11]  H. Carlson,et al.  Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism. , 2011, Chemistry & biology.

[12]  G. Mustata,et al.  Discovery of modulators of protein-protein interactions: current approaches and limitations. , 2011, Current topics in medicinal chemistry.

[13]  U. Fischer,et al.  Cellular strategies for the assembly of molecular machines. , 2010, Trends in biochemical sciences.

[14]  J. Gestwicki,et al.  High-Throughput Screen for Escherichia coli Heat Shock Protein 70 (Hsp70/DnaK) , 2010, Journal of biomolecular screening.

[15]  Clayton Carlson,et al.  Nucleating the Assembly of Macromolecular Complexes , 2010, Chembiochem : a European journal of chemical biology.

[16]  H. Carlson,et al.  Mutagenesis Reveals the Complex Relationships between ATPase Rate and the Chaperone Activities of Escherichia coli Heat Shock Protein 70 (Hsp70/DnaK)* , 2010, The Journal of Biological Chemistry.

[17]  J. Gestwicki,et al.  Pharmacological targeting of the Hsp70 chaperone. , 2009, Current topics in medicinal chemistry.

[18]  Paramjit S Arora,et al.  Assessment of helical interfaces in protein-protein interactions. , 2009, Molecular bioSystems.

[19]  Michelle R Arkin,et al.  The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. , 2009, Current opinion in chemical biology.

[20]  T. Berg Allosteric switches: remote controls for proteins. , 2009, Angewandte Chemie.

[21]  K. Williams,et al.  Development of Fluorescence Polarization Assays for the Molecular Chaperone Hsp70 Family Members: Hsp72 and DnaK , 2008, Current chemical genomics.

[22]  E. Giralt,et al.  Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy , 2008, Protein science : a publication of the Protein Society.

[23]  E. Zuiderweg,et al.  High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK. , 2008, Analytical biochemistry.

[24]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[25]  B. Chait,et al.  Determining the architectures of macromolecular assemblies , 2007, Nature.

[26]  Sara Linse,et al.  Methods for the detection and analysis of protein–protein interactions , 2007, Proteomics.

[27]  M. Jäättelä,et al.  The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions , 2007, FEBS letters.

[28]  Lila M Gierasch,et al.  Hsp70 chaperone ligands control domain association via an allosteric mechanism mediated by the interdomain linker. , 2007, Molecular cell.

[29]  Gregory T O'Donnell,et al.  Miniaturization of absorbance assays using the fluorescent properties of white microplates. , 2005, Analytical biochemistry.

[30]  M. Mayer,et al.  Hsp70 chaperones: Cellular functions and molecular mechanism , 2005, Cellular and Molecular Life Sciences.

[31]  Mitchell A. Avery,et al.  Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity , 2004, Hypertension.

[32]  P. Wittung-Stafshede,et al.  The J-domain of Hsp40 couples ATP hydrolysis to substrate capture in Hsp70. , 2003, Biochemistry.

[33]  S. N. Witt,et al.  Kinetic analysis of interdomain coupling in a lidless variant of the molecular chaperone DnaK: DnaK's lid inhibits transition to the low affinity state. , 2002, Biochemistry.

[34]  C. Roy,et al.  The road less traveled , 2002, The Journal of cell biology.

[35]  Bernd Bukau,et al.  Multistep mechanism of substrate binding determines chaperone activity of Hsp70 , 2000, Nature Structural Biology.

[36]  Shawn Y. Stevens,et al.  Structural insights into substrate binding by the molecular chaperone DnaK , 2000, Nature Structural Biology.

[37]  J. Reinstein,et al.  Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A Valencia,et al.  Mutations in the DnaK chaperone affecting interaction with the DnaJ cochaperone. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Christen,et al.  Control of the DnaK Chaperone Cycle by Substoichiometric Concentrations of the Co-chaperones DnaJ and GrpE* , 1998, The Journal of Biological Chemistry.

[40]  S. Rüdiger,et al.  Interaction of Hsp70 chaperones with substrates , 1997, Nature Structural Biology.

[41]  J Kuriyan,et al.  Crystal structure of the nucleotide exchange factor GrpE bound to the ATPase domain of the molecular chaperone DnaK. , 1997, Science.

[42]  J. Reinstein,et al.  GrpE accelerates nucleotide exchange of the molecular chaperone DnaK with an associative displacement mechanism. , 1997, Biochemistry.

[43]  J. Reinstein,et al.  Nucleotide-induced Conformational Changes in the ATPase and Substrate Binding Domains of the DnaK Chaperone Provide Evidence for Interdomain Communication (*) , 1995, The Journal of Biological Chemistry.

[44]  J. Reinstein,et al.  The role of ATP in the functional cycle of the DnaK chaperone system. , 1995, Journal of molecular biology.

[45]  M. Mayer,et al.  Allostery in the Hsp70 chaperone proteins. , 2013, Topics in current chemistry.

[46]  D. Scow,et al.  Leukotriene inhibitors in the treatment of allergy and asthma. , 2007, American family physician.

[47]  A. Baykov,et al.  A malachite green colorimetric assay for protein phosphatase activity. , 1991, Analytical biochemistry.

[48]  S. Lindquist,et al.  The heat-shock proteins. , 1988, Annual review of genetics.